Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Initiates Coverage On PMV Pharmaceuticals with Perform Rating

Oppenheimer analyst Jeff Jones initiates coverage on PMV Pharmaceuticals (NASDAQ:PMVP) with a Perform rating.

August 19, 2021

1 minute read

Oppenheimer analyst Jeff Jones initiates coverage on PMV Pharmaceuticals (NASDAQ:PMVP) with a Perform rating.

RBC Capital Maintains Outperform on Webster Financial, Raises Price Target to $68

Today, 11:34 AM

RBC Capital analyst Steven Duong maintains Webster Financial (NYSE:WBS) with a Outperform and raises the price target from $63 to $68.

Today, 11:34 AM

- Reuters

Today, 11:34 AM

Raymond James analyst Justin Jenkins maintains BP (NYSE:BP) with a Outperform and raises the price target from $39 to $40.

Today, 11:34 AM

Item 9 Labs Corp. (OTCQX: INLB) has secured the necessary financing to complete the previously announced acquisition of Sessions Cannabis